Original Article

You have full text access to this OnlineOpen article

Racial disparities in cancer therapy†

Did the gap narrow between 1992 and 2002?

  1. Cary P. Gross MD1,‡,*,
  2. Benjamin D. Smith MD2,
  3. Elizabeth Wolf BA1,
  4. Martin Andersen MPH1

Article first published online: 7 JAN 2008

DOI: 10.1002/cncr.23228

Issue

Cancer

Cancer

Volume 112, Issue 4, pages 900–908, 15 February 2008

Additional Information

How to Cite

Gross, C. P., Smith, B. D., Wolf, E. and Andersen, M. (2008), Racial disparities in cancer therapy. Cancer, 112: 900–908. doi: 10.1002/cncr.23228

Author Information

  1. 1

    Section of General Internal Medicine, Robert Wood Johnson Clinical Scholars Program, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut

  2. 2

    Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas

  1. ‡

    Fax: (203) 688-4092

*Yale University School of Medicine, Primary Care Center, 333 Cedar Street, PO Box 208025, New Haven, CT 06520

  1. †

    None of the authors have any significant conflicts of interest to declare.

Publication History

  1. Issue published online: 1 FEB 2008
  2. Article first published online: 7 JAN 2008
  3. Manuscript Accepted: 10 SEP 2007
  4. Manuscript Revised: 4 SEP 2007
  5. Manuscript Received: 25 JUN 2007

Funded by

  • Beeson Career Development Award. Grant Number: 1 K08 AG24842
  • Eliminating Cancer Disparities of the Yale Comprehensive Cancer Center
  • American Society of Clinical Oncology Young Investigator Award

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (105K)

REFERENCES

  • 1
    Committee on Cancer Research Among Minorities and the Medically Underserved. The Unequal Burden of Cancer: An Assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved. Institute of Medicine; 1999.
  • 2
    Shavers VL,Brown ML,Potosky AL, et al. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med. 2004; 19: 146–155.
    Direct Link:
  • 3
    Ward E,Jemal A,Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54: 78–93.
    Direct Link:
  • 4
    Bach PB,Cramer LD,Warren JL,Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999; 341: 1198–1205.
  • 5
    Bradley CJ,Given CW,Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002; 94: 490–496.
  • 6
    Shavers VL,Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334–357.
  • 7
    Harlan LC,Clegg LX,Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol. 2003; 21: 3488–3494.
  • 8
    Schrag D,Gelfand SE,Bach PB,Guillem J,Minsky BD,Begg CB. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results–Medicare. J Clin Oncol. 2001; 19: 3712–3718.
  • 9
    Schrag D,Cramer LD,Bach PB,Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001; 93: 850–857.
  • 10
    Baldwin LM,Dobie SA,Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005; 97: 1211–1220.
  • 11
    Haggstrom DA,Quale C,Smith-Bindman R. Differences in the quality of breast cancer care among vulnerable populations. Cancer. 2005; 104: 2347–2358.
    Direct Link:
  • 12
    Wingo PA,Ries LA,Rosenberg HM,Miller DS,Edwards BK. Cancer incidence and mortality, 1973–1995: a report card for the U.S. Cancer. 1998; 82: 1197–1207.
    Direct Link:
  • 13
    NCI Plan and Budget Proposal for Fiscal Year 2007. Bethesda, Md: National Cancer Institute; 2006.
  • 14
    Trans-HHS Cancer Health Disparities Progress Review Group. Making Cancer Health Disparities History. Washington, DC: U.S. Department of Health and Human Services; 2004.
  • 15
    Kennedy EM. The role of the federal government in eliminating health disparities. Health Aff (Millwood). 2005; 24: 452–458.
  • 16
    Mitka M. Initiative seeks answers to cancer disparities. JAMA. 2000; 283: 2092–2093.
  • 17
    Underwood W3rd,Jackson J,Wei JT, et al. Racial treatment trends in localized/regional prostate carcinoma: 1992–1999. Cancer. 2005; 103: 538–545.
    Direct Link:
  • 18
    Underwood W,De Monner S,Ubel P,Fagerlin A,Sanda MG,Wei JT. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol. 2004; 171: 1504–1507.
  • 19
    Zeliadt SB,Potosky AL,Etzioni R,Ramsey SD,Penson DF. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology. 2004; 64: 1171–1176.
  • 20
    Jessup JM,Stewart A,Greene FL,Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005; 294: 2703–2711.
  • 21
    Ries L,Eisner M,Kosary C, et al. SEER Cancer Statistics Review, 1975–2003. In: http://seer.cancer.gov/csr/1975_2003/ based on November 2005 SEER data submission, posted to the SEER web site, 2006, vol. 2006. Bethesda, Md: National Cancer Institute; 2006.
  • 22
    NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990; 264: 1444–1450.
  • 23
    Blichert-Toft M,Rose C, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr. 1992: 19–25.
  • 24
    Muggia F, ed. National Cancer Institute: Physician Data Query. Available from http://www.cancer.gov/cancertopics/pdq. Accessed on November 1, 2007.
  • 25
    Sarrazin D,Le MG,Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989; 14: 177–184.
  • 26
    van Dongen JA,Bartelink H,Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992: 15–18.
  • 27
    Ayanian JZ,Zaslavsky AM,Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003; 21: 1293–1300.
  • 28
    Lathan CS,Neville BA,Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol. 2006; 24: 413–418.
  • 29
    Mandelblatt JS,Kerner JF,Hadley J, et al. Variations in breast carcinoma treatment in older medicare beneficiaries: is it black or white. Cancer. 2002; 95: 1401–1414.
    Direct Link:
  • 30
    Neugut AI,Fleischauer AT,Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002; 20: 2643–2650.
  • 31
    Voti L,Richardson LC,Reis I,Fleming LE,Mackinnon J,Coebergh JW. The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Res Treat. 2006; 95: 89–95.
  • 32
    Bach PB,Guadagnoli E,Schrag D,Schussler N,Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 2002; 40( 8 suppl): IV-19–25.
  • 33
    Klabunde CN,Potosky AL,Legler JM,Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000; 53: 1258–1267.
  • 34
    Keating NL,Landrum MB,Ayanian JZ,Winer EP,Guadagnoli E. The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries. J Gen Intern Med. 2005; 20: 38–44.
    Direct Link:
  • 35
    Smedley BD,Stith AY,Nelson AR. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2003.
  • 36
    Department of Health and Human Services, Centers for Disease Control and Prevention. http://www.cdc.gov/tobacco/tobacco_control_programs/stateandcommunity/index.htm#about Atlanta, Ga: Centers for Disease Control and Prevention; 2006. Accessed on November 1, 2007.
  • 37
    Department of Health and Human Services. Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program, 1991–2002 National Report. Available at: http://www.cdc.gov/cancer/nbccedp/bccpdfs/national_report.pdf Atlanta, Ga: Centers for Disease Control and Prevention.
  • 38
    Lamont EB,Herndon JE2nd,Weeks JC, et al. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants. J Natl Cancer Inst. 2005; 97: 1080–1083.
  • 39
    Lamont EB,Lauderdale DS,Schilsky RL,Christakis NA. Construct validity of medicare chemotherapy claims: the case of 5FU. Med Care. 2002; 40: 201–211.
  • 40
    Bach PB,Schrag D,Brawley OW,Galaznik A,Yakren S,Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002; 287: 2106–2113.
  • 41
    Sundararajan V,Mitra N,Jacobson JS,Grann VR,Heitjan DF,Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med. 2002; 136: 349–357.
  • 42
    Super N. Medigap: Prevalence, Premiums, and Opportunities for Reform. In: National Health Policy Forum. NHPF Issue Brief No.782, September 9, 2002. Available at: http://www.nhpf.org/pdfs_ib/IB782_Medigap_9-9-02.pdf#search=%22medigap%20use%20by%20race%22
  • 43
    Jha AK,Fisher ES,Li Z,Orav EJ,Epstein AM. Racial trends in the use of major procedures among the elderly. N Engl J Med. 2005; 353: 683–691.
  • 44
    Vaccarino V,Rathore SS,Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005; 353: 671–682.
  • 45
    Satcher D,Fryer GEJr,McCann J,Troutman A,Woolf SH,Rust G. What if we were equal? A comparison of the black-white mortality gap in 1960 and 2000. Health Aff (Millwood). 2005; 24: 459–464.
  • 46
    Dohan D,Schrag D. Using navigators to improve care of underserved patients: current practices and approaches. Cancer. 2005; 104: 848–855.
    Direct Link:
  • 47
    National Cancer Institute. NCI Awards $25 Million for Patient Navigator Research Program for Minority and Underserved Cancer Patients. Posted October 27, 2005 to: http://www.cancer.gov/newscenter/pressreleases/Patient NavigatorGrants
  • 48
    Trivedi AN,Zaslavsky AM,Schneider EC,Ayanian JZ. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med. 2005; 353: 692– 700.
  • 49
    Fiscella K,Franks P,Gold MR,Clancy CM. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000; 283: 2579–2584.
  • 50
    Lurie N. Health disparities—less talk, more action. N Engl J Med. 2005; 353: 727–729.
  • 51
    Malin JL,Schneider EC,Epstein AM,Adams J,Emanuel EJ,Kahn KL. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006; 24: 626–634.
  • 52
    Roetzheim RG, Gonzalez EC,Ferrante JM,Pal N,Van Durme DJ,Krischer JP. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer. 2000; 89: 2202–2213.
    Direct Link:
  • 53
    Du XL, Osborne C,Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol. 2002; 20: 4636–4642.
  • 54
    Klabunde CN, Potosky AL,Harlan LC,Kramer BS. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care. 1998; 36: 1337–1348.
View Full Article (HTML) Get PDF (105K)